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bstract
bjectives  The aim of this study was to examine the validity of the International Physical Activity Questionnaire Short Form (IPAQ-SF) as
 measure of physical activity (PA) in young people with cerebral palsy (CP).
esign  Cross-sectional.
etting  Participants were recruited through 8 National Health Service (NHS) trusts, one school, one university and through organisations
hat provide services for people with disabilities in England.
articipants  Sixty-four, ambulatory young people aged 10–19 years with CP [Gross Motor Function Classification System (GMFCS) levels
–III] participated in this study.
ain  outcome  measure  The IPAQ-SF was administered to participants. Participants were then asked to wear a wGT3X-BT triaxial accelerom-
ter (ActiGraph, Pensacola, FL) for 7 days to objectively assess PA. Time spent in sedentary behaviour, in moderate to vigorous PA (MVPA)
nd in total PA (TPA) was compared between measures.
esults  Young people with CP self-reported less time in sedentary behaviour and underestimated the time spent in TPA, when compared
o accelerometer measurements. Bland–Altman plots demonstrated poor agreement between the measures for MVPA, with upper and lower
5% limits of agreement of −147 to 148.9 minute. After adjusting for gender and GMFCS level, age was a predictor of the difference between
easures for MVPA (P  < 0.001) and TPA (P  < 0.001).
onclusions  These findings suggest that the IPAQ-SF is not a valid method of measuring TPA or sedentary behaviour in young people with
P and it is not appropriate for use when assessing an individual’s time in MVPA. Therefore, where feasible, an objective measure of PAhould be used.
linical  trial  registration  number  ISRCTN90378161.
 2019 The Authors. Published by Elsevier Ltd on behalf of Chartered So
Y license (http://creativecommons.org/licenses/by/4.0/).
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ntroduction
Cerebral Palsy (CP) is a non-progressive, neurodevelop-
ental condition defined as ‘a group of permanent disorders
f the development of movement and posture, causing activity
imitation that are attributed to non-progressive disturbances
hat occurred in the developing foetal or infant brain’ [1]. It is
he most common form of childhood physical disability, with
n incidence of 1.5–3.8 per 1000 births reported worldwide
2]. CP is a life-long condition and the transition into ado-
escence and adulthood is often accompanied by a decline in
hysical function [3], which may be associated with reduced
articipation in physical activity (PA). Children and adoles-
ents with CP participate in less PA and spend more time in
edentary behaviour compared to their typically developing
eers [4,5]. Given recent evidence of the increased preva-
ence of non-communicable diseases (NCDs), such as stroke
nd ischaemic heart disease, among people with CP [6,7],
onitoring PA levels among people with CP is paramount.
espite the importance of promoting PA, as a potential mod-
fiable risk factor for the prevention of NCDs and functional
ecline over time, there is a paucity of validated self-report
easures of PA among young people with CP.
Self-reported measures of PA include questionnaires,
ctivity diaries, logs and interviews. Many of these sub-
ective measures are used as population screening tools as
hey are relatively cheap and easy to administer. In an effort
o improve consistency in the monitoring of PA using self-
eport measures, a number of standardised PA questionnaires
ave been developed and validated in a range of participant
ohorts. These include the Bouchard 3-day Physical Activ-
ty Record [8], the Minnesota Leisure-time Physical Activity
uestionnaire [9] and the International Physical Activity
uestionnaire (IPAQ) [10]. These PA questionnaires ask indi-
iduals to recall the PA they have engaged in over a set time
rame, ranging from periods of 3 days [8] to 1 year [9].
The International Physical Activity Questionnaire Short-
orm (IPAQ-SF) is one of the most widely used self-report
uestionnaires to assess PA. It consists of seven questions to
apture average daily time spent sitting, walking, and engag-
ng in moderate and vigorous PA over the last seven days.
eveloped by an International Consensus Group in 1998, the
est-retest reliability, and concurrent and criterion validity, of
he IPAQ were examined across 12 countries, among peo-
le aged 16–69 years of age [10]. However, less is known
bout its validity in younger adolescents and it has not been
alidated for use in people with CP. The most recent system-
tic review to examine the validity of the IPAQ-SF included
3 studies, of which only 2 studies included people with a
ean age of less than 18 years [11]. The review concluded
hat, based on weak correlations between the IPAQ and mea-
ures of objective PA (e.g. accelerometry), the IPAQ was not valid measure of PA. Since the publication of this review,
wo studies have examined the validity of the IPAQ-SF in
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ut in healthy pre pubertal boys [12] and young people with
uvenile dermatomyositis and juvenile systematic lupus ery-
hematosus [13], respectively. Both studies demonstrated that
he IPAQ-SF was not a valid measure of assessing moderate-
o-vigorous PA (MVPA) at an individual level. While the
PAQ-SF is widely used and may present as a feasible method
f assessing PA in young people with CP, evidence of its
alidity in this population is required. The aim of this study
as therefore to examine the validity of the IPAQ-SF as a
easure of PA in young people with CP. The Strengthen-
ng the Reporting of Observational Studies in Epidemiology
STROBE) statement checklist guided the reporting of this
tudy [14].
ethods
esign  &  participants
This study was nested within a randomised controlled trial
RCT) examining the feasibility, acceptability and efficacy of
esistance training for adolescents with cerebral palsy. The
ecruitment and selection criteria have already been previ-
usly reported elsewhere [15]. The data for this study was
ollected as part of the routine assessments of this larger
CT. Ambulatory young people with CP were invited to
ake part in this study. Adolescents with CP were recruited
rom 8 National Health Service (NHS) trusts in England, a
pecial education needs school, a university, a primary care
rganisation, national organisations for people with disabil-
ties and through word of mouth. Informed written consent
as obtained from participants aged 16 years and older, and
nformed written assent was obtained from participants less
han 16 years, prior to participation in the study. For partic-
pants less than 16 years, parental/guardian written consent
as also obtained. Inclusion criteria were: (1) spastic CP
ged 10–19 years; (2) the ability to walk independently with
r without a mobility aid (USA. Gross Motor Function Clas-
ification System [GMFCS] levels I–III) and (3) the ability to
ctivate the ankle plantarflexors (a criteria relating to inclu-
ion in the RCT). Exclusion criteria were: (1) orthopaedic
urgery of the lower extremities in the past 12 months; (2)
otulinum toxin type A injections in the past 6 months; (3)
erial casting in the past 6 months and (4) insufficient cogni-
ive understanding to comply with the assessment procedures.
esting  procedures
Participants and/or their parents completed a demographic
uestionnaire providing information on age, gender, and
MFCS level. Parent reported GMFCS level was reviewed
nd verified by retrospective video analysis of participants
y two physiotherapists (WL, JR). Participants’ body mass
as measured to the nearest 0.1 kg using either a standing
SECA, Hamburg, Germany) or seated (Marsden, Rother-
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tatus. Height was also recorded to the 0.1 cm using a Leices-
er portable height measure (Marsden, Rotherham, UK).
The IPAQ-SF was self-administered to all participants
sing the standardised instructions accompanying the IPAQ.
ssistance was provided by the researcher to read the ques-
ions if required. Further, the young person was allowed to ask
heir parent/guardian or researcher for assistance to answer
he questions if required. Data were largely cleaned accord-
ng to the IPAQ scoring protocol [16], with the exception of
he guidance relating to the normalisation of the distribution
f levels of activity [10] as follows: (1) high values were not
runcated to 4 hours; (2) outliers were not excluded without
 valid reason; (3) reported durations of less than 10 minutes
ere not removed. If applied, these guidelines would have
hanged the original responses given by participants, which
as deemed inappropriate given that the aim of the study
as to validate self-reported PA as measured by the IPAQ-
F. Data from the moderate and vigorous activity domains
ere summed to generate a MVPA variable. Finally, total PA
TPA) was calculated by summing time spent walking and in
VPA, in accordance with the scoring protocol [16].
Participants were asked to wear a wGT3X-BT triaxial
ccelerometer (ActiGraph, Pensacola, FL) for 7 days to
bjectively assess PA. This accelerometer was chosen as
t has shown to be a reliable and valid measure of habit-
al physical activity in ambulant children and adolescents
ith CP [17,18]. The monitor was worn on the waist above
he right hip or least affected side in the case of significant
symmetry, in the midaxillary line. Standardised written and
erbal instructions were provided to participants during their
ssessment. The monitor was worn during waking hours and
ata were collected at a sampling rate of 30 Hz. Participants
ere asked to remove the monitor during periods of sleeping,
athing or swimming, and to note the time it was put on and
aken off each day in an activity log.
Data was exported from the device in 15 second epochs
sing ActiLife software, Version 16.3.3 (ActiGraph, Pen-
acola, FL). Participants with at least two days of monitoring
ere included in the final analysis, as two days of data
s necessary to achieve a reliability coefficient of 0.70 for
dolescents with CP [17]. Furthermore, a valid day was clas-
ified as at least 8 hours of wear time [17]. Participants not
eeting these criteria were removed from the analysis. An
lgorithm developed by Choi et al.  [19] was applied to iden-
ify periods when the monitor was not worn (i.e. non-wear
ime). Non-wear time was defined as a period ≥90 minutes
f no movement with a spike tolerance of 2 minutes (i.e. ≥90
onsecutive 0’s, until more than 2 minutes of non-zeros are
etected). Where available, activity logs were used to verify
on-wear time. Non wear-time was removed before analysing
he data.
The wGT3X-BT accelerometer generates a variable out-
ut voltage signal, proportional to acceleration in three
rthogonal planes (vertical, anteroposterior and mediolat-
ral), which are converted to vector magnitude activity counts
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pent in sedentary behaviour, light physical activity (LPA)
nd MVPA, using previously validated cut-points for adoles-
ents with CP [18]. For people in GMFCS level I, II and III,
edentary behaviour was <72 counts per 15 second. For peo-
le in GMFCS level I LPA was 72–723 counts per 15 second,
nd MVPA was ≥724 counts per 15 second. For people in
MFCS level II, LPA was 72–684 counts per 15 second,
nd MVPA was ≥685 counts per 15 second. For people in
MFCS level III, LPA was 72–668 counts per 15 second, and
VPA was ≥669 counts per 15 second. The average time
pent at each PA intensity (sedentary behaviour, LPA and
VPA) per day was calculated by dividing total time in each
ntensity by the number of days on which the accelerometer
as worn. TPA was calculated by summing time in LPA and
VPA.
ata  analysis
The distribution of data was examined using histograms,
-Q plots and cross-tabulations. Descriptive statistics were
sed to report participant characteristics and PA data. As
ear time for the accelerometer and MVPA and TPA
ecorded by the IPAQ were not normally distributed, medi-
ns, interquartile ranges and ranges were reported. Means,
tandard deviations and ranges were reported for accelerom-
ter data and for sedentary time data from the IPAQ-SF, as
hey were normally distributed. There was no evidence that
he difference between accelerometer and IPAQ-SF measured
A variables was not normally distributed, and therefore the
ean differences and associated 95% confidence intervals
re presented. Bland–Altman plots were plotted [20] and
5% limits of agreement (LOA) were calculated to evaluate
greement between accelerometer and IPAQ-SF measured
A variables. Finally, a multivariable linear regression model
as fitted to examine if age, gender or GMFCS level were
ssociated with the difference between self-reported and
bjectively measured PA. Scatter plots of residuals against
tted values, and histograms and Q-Q plots of residuals were
sed to examine if the assumptions of linear regression were
et. There was no evidence that assumptions were not met
or regression models.
esults
Sixty-four young people participated in this study. Of
hese, four did not have valid accelerometer data, one per-
on did not complete the IPAQ-SF, and a further person was
issing both accelerometer and IPAQ-SF data. Fifty-eight
eople were included in the analysis. Descriptive character-
stics are presented in Table 1. Some participants did not
rovide answers for all questions on the IPAQ-SF; 55 partici-
ants reported sitting time and walking time, respectively, and
6 reported MVPA. Tables 2 and 3 report the average daily
inutes spent in each PA domain from the accelerometer and
he IPAQ-SF, respectively.
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Table 1
Participant characteristics (n = 58).
Variable
Gender
Male, n (%) 33 (57)
Female, n (%) 25 (43)
Age, yr
Mean (SD) 13.6 (2.5)
Range 10 to 19
Height, cm
Mean (SD) 154.2 (12.5)
Range 131.5 to 180.9
Mass, kg
Mean (SD) 49.1 (13.6)
Range 27.4 to 78.5
Distribution
Unilateral, n (%) 27 (47)
Bilateral, n (%) 31 (53)
GMFCS
Level I, n (%) 25 (43)
Level II, n (%) 23 (40)
Level III, n (%) 10 (17)
Education level
Primary, n (%) 11 (19)
Secondary, n (%) 42 (72)
University, n (%) 3 (5)











































eter was poor, with LOA suggesting that, at an individual















MFCS: Gross Motor Function Classification System.
Participants reported less time in sedentary behaviour
ompared to accelerometer data (mean diff: 133 minute, 95%
I 85 to 182). Mean time spent in MVPA and TPA, respec-
ively, was also lower when reported using the IPAQ-SF
n comparison to accelerometer data (mean diff in MVPA:
 minute, 95% CI −19 to 21; mean diff in TPA: 137 minute,
5% CI 103 to 170). Bland–Altman plots demonstrated
oor agreement between the two measures when measur-
ng MVPA, with upper and lower 95% LOA of −147 to





ummary of physical activity data as measured by wGT3X-BT accelerometer and 
n Mean (SD) 
GT3X-BT accelerometer
ear time (days)a 58 
ear time (minute)a 58 
ed (minute) 58 522 (144) 
VPA (minute) 58 54 (29) 
PA (minute) 58 242 (76) 
PAQ-SF
ed (minute) 55 393 (151) 
VPA (minute)a 56 
PA (minute)a 54 
PAQ-SF: International Physical Activity Questionnaire-Short Form; Sed: sedentary;
D: standard deviation; IQR: interquartile range.
a Not normally distributed.y 107 (2020) 209–215
Individual differences between the wGT3X-BT and the
PAQ-SF ranged from −206 to 686 minute for sedentary
ehaviour, −336 to 131 minute for MVPA and −174 to
80 minute for TPA. When examining predictors of the dif-
erence between measures, there was strong evidence that
ge was associated with the difference in MVPA and TPA
etween measures, after adjusting for gender and GMFCS
evel. For every additional year in age, the difference in
VPA and TPA, respectively, between the wGT3X-BT and
he IPAQ-SF reduced by 18 minute (95% CI 11 to 25,
 < 0.001) and 23 minute (95% CI 11 to 35, P < 0.001). On
verage, participants aged 10 years underestimated MVPA
nd TPA, respectively, by 53 minute (95% CI 18 to 89) and
49 minute (95% CI 188 to 311). The magnitude of this
nderestimation reduced with age for both MVPA and TPA.
owever, this resulted in participants age 19 years, on aver-
ge, overestimating MVPA by 107 minute (95% CI 59 to
55), while there was no difference between measures for
PA at 19 years (mean diff: 43, 95% CI −40 to 126). Finally,
here was very weak evidence that regardless of age and gen-
er, people in GMFCS level III underestimated MVPA by
0 minute (95% CI −0.25 to 100) when using the IPAQ-SF,
ompared to people in GMFCS level I. There was no differ-
nce between people in GMFCS levels I and II (P  = 0.57) or
n GMFCS levels II and III (P  = 0.13).
iscussion
This is the first study to examine the validity of the IPAQ-
F in young people with CP. While young people with
P self-reported less time in sedentary behaviour, they also
nderestimated the time spent in TPA when compared to
bjective PA data. The mean of the difference between time
n self-reported and objectively-measured MVPA was small.
owever, agreement between the IPAQ-SF and accelerom-stimated by 147 minute when assessed with the IPAQ-SF.
fter adjusting for gender and GMFCS level, age was a pre-
IPAQ-SF, respectively.
Median (IQR) Range
7 (6 to 7) 2 to 7





29 (17 to 64) 0 to 360
63 (30 to 148) 9 to 407
 MVPA: moderate to vigorous physical activity; TPA: total physical activity;
G. Lavelle et al. / Physiotherapy 107 (2020) 209–215 213
Table 3
Multivariable regression analyses examining associations with the difference between wGT3X-BT accelerometer and IPAQ-SF measured physical activity,
respectively.
Independent variable  (95% confidence interval) P value
Dependent variable: difference in sedentary behaviour (wGT3X-BT – IPAQ-SF), n = 55
Age 13 (−7 to 33) 0.194
Gender (reference: male) −58 (−156 to 41) 0.244
GMFCS (reference: level I)
Level II 51 (−57 to 159) 0.350
Level III 38 (−104 to 180) 0.595
Dependent variable: difference in MVPA (wGT3X-BT – IPAQ-SF), n = 56
Age −18 (−25 to −11) <0.001
Gender (reference: male) −1 (−35 to 34) 0.972
GMFCS (reference: level I)
Level II 10 (−27 to 48) 0.574
Level III 50 (−0.25 to 100) 0.051
Dependent variable: difference in TPA (wGT3X-BT – IPAQ-SF), n = 54
Age −23 (−35 to −11) <0.001
Gender (reference: male) −19 (−81 to 42) 0.524
GMFCS (reference: level I)
Level II −37 (−103 to 29) 0.264
Level III −44 (−132 to 44) 0.317












































PAQ-SF: International Physical Activity Questionnaire-Short Form; Sed: sed
PA: total physical activity.
ictor of the difference between measures. However, there
as no evidence that gender was an independent predictor
f the difference between measures, and very weak evidence
hat GMFCS level was a predictor, after adjusting for age and
ender.
The results of this study are unsurprising given evidence
rom previous studies that self-report tools provide imprecise
nformation on PA [21]. A review of 130 PA questionnaires
rom 96 different studies determined that median validity
oefficients ranged from as low as 0.25–0.41 for newly
evised questionnaires [22]. The most recent review of the
alidity of the IPAQ-SF included 23 studies and found that
he IPAQ-SF overestimated PA by, on average, 84%, when
ompared to an objective criterion. In this same review Lee
t al.  [11] found that the correlations between the IPAQ-SF
nd criterion measures for TPA were very weak (ranging from
.09 to 0.39).
Overall, the IPAQ-SF was not a valid measure of TPA
hen compared to accelerometry in this sample of young
eople with CP. This agrees with previous studies of the
PAQ-SF in Chinese [23], Norweigan [24], Vietnamese [25]
nd Estonian [12] adolescents with typical development,
hich reported poor validity of the IPAQ-SF. We only found
ne study that examined the validity of the IPAQ-SF in
 “clinical” population of adolescents [13], which found
eak correlations (r = 0.03–0.33) between the IPAQ-SF and
ccelerometry data in young people with rheumatic condi-
ions. Similar to the findings in young people with CP, the
PAQ-SF highly underestimated sedentary time in people
ith juvenile dermatomyositis and juvenile systematic lupusrythematosus (mean bias 106 and 36 minute, respectively).
Although the mean differences for MVPA was small, there







P, suggesting that it is not an appropriate measure of an indi-
idual’s MVPA activity levels. This is supported by highly
ariable mean bias (−59 to 90 minute) of MVPA found in
 previous study, between IPAQ-SF and accelerometry in
hose with rheumatic conditions [13]. Likewise, Raask et  al.
12], also concluded that the IPAQ-SF should not be used
s an individual-level estimate of MVPA in healthy male
dolescents.
It is interesting to note that although young people with
P underestimated their self-reported time spent in sedentary
ctivity and therefore were more sedentary than perceived,
PA was also underestimated, using the IPAQ-SF. This
mphasises that the IPAQ-SF is neither a valid measure
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nd/or unconscious under reporting of activity performed, or
 failure to recall PA or time spent sedentary accurately (i.e.
ecall bias) may be provided as rationale for the observed
ndings. However the findings of poor agreement between
easures may also be attributed to the wording of the IPAQ-
F. Erroneous interpretation of some questions and duplicity
f entries across domains for the same single bout of activ-
ty performed may be a source of error. The IPAQ-SF asks
ndividuals to separate walking time and moderate activity.
owever, it is likely that some individuals achieve moderate
ntensity activity through walking, which may be particularly
rue for people with CP [26]. This concern has also been
ited by others researchers, who argue separating walking
nd moderate activity leads to confusion for the reader [27].
n addition to the unavoidable recall bias inherent with PA
uestionnaires, the examples given on the IPAQ-SF for each
A domain may also contribute to the significant differences
bserved. For example, moderate activity examples include
arrying light loads, bicycling at a regular pace, or doubles
ennis. These examples may also be misleading for the age
roup studied if they do not engage in these activities.
It is also interesting to note that there was strong evidence
hat age was associated with the difference in MVPA and TPA
etween measures, after adjusting for gender and GMFCS
evel. It may be suggested that perhaps older participants are
ore capable of estimating TPA or potentially have reduced
ecall bias, but not necessarily able to differentiate between
alking and MVPA. Additionally, older participants may be
ore cognisant of the level of MVPA that they should be
ngaged in, and therefore are more likely to overestimate the
ime they have spent in MVPA when completing the IPAQ-SF.
nother point to note is that the aim of the IPAQ-SF is to mea-
ure activity bouts of 10 minute or longer, as is reflected in the
ording of the questions; while an accelerometer will collect
ata of any duration and indicate a corresponding intensity
evel. This is another partial explanation for the discrepancies
etween the readings between measures.
A major strength of this study is the inclusion of a pre-
iously validated accelerometer for young people with CP,
hich was used as the objective comparison measure. How-
ver, it must also be noted that there are limitations when
sing and analysing accelerometer data. A major drawback
f such devices is their inability to capture the metabolic cost
ssociated with standing, static work, upper body movements
nd vertical lifting [28]. It is also not an accurate measure of
omplex movements e.g. cycling. Upper body movement is
ften underestimated as the device is worn at hip level and the
evice cannot be worn for water-based activities. The latter
wo limitations are particularly noteworthy given that some
f the participants in this study use a wheelchair on occasion
o mobilise and that swimming is often the preferred sport of
hoice for people with CP. Further, while the actigraph has
een used as the criterion measure of PA in this study, it is
ot considered a gold standard measure of PA. However, gold
tandard measures of PA (e.g. doubly labelled water, indirect
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ver 7 days in this study. While the results of this study pro-
ide an insight on age, gender and GMFCS level as predictors
f the magnitude of the difference between the two measures
t is acknowledged that other factors (e.g. sociodemographic
nd environmental factors) which we have not examined, may
ave an influence and should be considered in future studies.
onclusion
In conclusion, the findings of this study suggest that
he IPAQ-SF is not a valid method of measuring TPA or
edentary behaviour in young people with CP. While the
ean differences were small between measures for MVPA
oor agreement was demonstrated, indicating that the IPAQ
s not appropriate for use when assessing an individual’s time
n MVPA. Therefore, where feasible, an objective measure
f PA should be used. Future research should focus on the
evelopment of a valid measure of self-report PA for use in
dolescents with CP, given the importance of promoting PA
n this population. However, it may be unrealistic to expect
ny self-report measure to provide an accurate indication
f an individual’s time spent in MVPA or sedentary time;
t may be more appropriate to use self-report measures to
btain a summary of an individual’s overall activity status.
Key  messages
• Despite the importance of promoting physical activ-
ity (PA), as a potential modifiable risk factor for the
prevention of non-communicable diseases and func-
tional decline over time, there is a paucity of validated
self-report measures of PA among young people with
CP.
• This is the first study to examine the validity of a
self-report physical activity (PA) questionnaire [Inter-
national Physical Activity Questionnaire Short Form
(IPAQ-SF)] as a measure of PA in young people with
cerebral palsy (CP), when compared to objectively
gathered accelerometer data.
• This work highlights that the IPAQ-SF is not a valid
method of measuring total PA or sedentary behaviour
in young people with CP. Additionally, poor agree-
ment between measures was observed for moderate
to vigorous PA. This study highlights that where fea-
sible an objective measure of PA should be used to
monitor activity levels in young people with CP.
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